Keywords: کاهش افت انعکاسی; DES; drug-eluting stent; TLR; target lesion revascularization; SES; sirolimus-eluting stent; ACS; acute coronary syndrome; PCI; percutaneous coronary intervention; SCAD; stable coronary artery disease; RD; reference diameter; MLD; minimum lumen diameter;
مقالات ISI کاهش افت انعکاسی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment
Keywords: کاهش افت انعکاسی; drug-coated balloon; drug-eluting balloon; femoropopliteal segment; late lumen loss; paclitaxel; patency; peripheral artery disease; peripheral vascular diseases; popliteal artery; restenosis; stenosis; superficial femoral artery; ABI; ankle-brachial in
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold
Keywords: کاهش افت انعکاسی; bioresorbable; coronary; scaffold; sirolimus-eluting; BRS; bioresorbable scaffold; DES; drug-eluting stent(s); ITT; intention-to-treat; LLL; late lumen loss; MACE; major adverse cardiac events(s); MI; myocardial infarction; MLD; minimum lumen diameter; P
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis)
Keywords: کاهش افت انعکاسی; drug-eluting balloon; extended release; in-stent restenosis; porous angioplasty balloon; sirolimus nanoparticle; BMS; bare-metal stent(s); DES; drug-eluting stent(s); ISR; in-stent restenosis; ITT; intention to treat; LLL; late lumen loss; MACE; major adv
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial
Keywords: کاهش افت انعکاسی; Drug-coated stent; Biolimus A9; Late lumen loss; Polymer-free drug-eluting stent;
Acotec Drug-Coated Balloon Catheter
Keywords: کاهش افت انعکاسی; drug-coated balloon catheter; femoropopliteal disease; randomized clinical trial; restenosis inhibition; ABI; ankle-brachial index; DCB; drug-coated balloon; LLL; late lumen loss; TLR; target lesion revascularization;
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up
Keywords: کاهش افت انعکاسی; angiography; coronary artery disease; follow-up studies; intravascular imaging; long-term; tomography; optical coherence; ID; ischemia-driven; IVUS; intravascular ultrasound; LLL; late lumen loss; MACE; major adverse cardiac event(s); MLD; minimum lumen d
Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4-Â and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial
Keywords: کاهش افت انعکاسی; biolimus; carrier-free; coronary artery disease; drug-coated stent(s); percutaneous coronary intervention; polymer-free; BFD; BioFreedom; DCS; drug-coated stent(s); DES; drug-eluting stent(s); FU; follow-up; LD; “low dose”; LLL; late lumen loss; NIH;
Drug-eluting balloons in patients with non-ST elevation acute coronary syndrome
Keywords: کاهش افت انعکاسی; Acute coronary syndrome; Drug-eluting balloons; Bare-metal stents; Late lumen loss;
Prospective study to evaluate safety and efficacy of Zotarolimus Eluting Stent (PSEZES) in patients with long coronary artery lesions
Keywords: کاهش افت انعکاسی; Zotarolimus Eluting Stent; Long lesion; Target lesion failure; Late lumen loss; Stent thrombosis
Angioplasty of Femoral-Popliteal Arteries With Drug-Coated Balloons: 5-Year Follow-Up of the THUNDER Trial
Keywords: کاهش افت انعکاسی; angioplasty; drug-coated balloon; femoral artery; long-term outcome; paclitaxel; peripheral arterial disease; CM; contrast medium; CRF; case report form; FU; follow-up; LLL; late lumen loss; PCB; paclitaxel-coated balloon; SAE; serious adverse event(s); T
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds
Keywords: کاهش افت انعکاسی; coronary artery disease; drug-eluting stent(s); late lumen loss; myocardial infarction; percutaneous coronary intervention; ACS; acute coronary syndrome(s); ARC; Academic Research Consortium; BES; biolimus-eluting stent(s); BVS; bioresorbable vascular sc
Meta-Analysis of Drug-Eluting Balloon Angioplasty and Drug-Eluting Stent Placement for Infrainguinal Peripheral Arterial Disease
Keywords: کاهش افت انعکاسی; BMS; bare metal stent; DEB; drug-eluting balloon; DES; drug-eluting stent; GRADE; Grades of Recommendation Assessment, Development, and Evaluation; LLL; late lumen loss; OR; odds ratio; PAD; peripheral arterial disease; PTA; percutaneous transluminal angi
Direct Drug-Eluting Stenting to Reduce Stent Restenosis : A Randomized Comparison of Direct Stent Implantation to Conventional Stenting With Pre-Dilation or Provisional Stenting in Elective PCI Patients
Keywords: کاهش افت انعکاسی; direct stenting; late lumen loss; percutaneous coronary intervention; pre-dilation; provisional stenting; restenosisACC/AHA, American College of Cardiology/American Heart Association; BMS, bare-metal stent(s); CABG, coronary artery bypass grafting; CS, co
A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis: Results From the PEPCAD China ISR Trial
Keywords: کاهش افت انعکاسی; in-stent restenosis; paclitaxel-coated balloon(s); paclitaxel-eluting stent(s); BMS; bare-metal stent(s); CI; confidence interval(s); DES; drug-eluting stent(s); ISR; in-stent restenosis; LLL; late lumen loss; MLD; minimal lumen diameter(s); PCB; paclitax
A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions
Keywords: کاهش افت انعکاسی; coronary artery disease; drug-eluting stent(s); percutaneous coronary intervention; randomized controlled trial; CK; creatine kinase; DES; drug-eluting stent(s); IVUS; intravascular ultrasound; LLL; late lumen loss; MI; myocardial infarction; PF; polymer-
Randomized Comparison of a Polymer-Free Sirolimus-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent in Patients With Diabetes Mellitus : The LIPSIA Yukon Trial
Keywords: کاهش افت انعکاسی; diabetes mellitus; late lumen loss; paclitaxel; sirolimus; stentsBMS, bare-metal stent(s); DES, drug-eluting stent(s); MLD, minimal luminal diameter; QCA, quantitative coronary angiography
Late lumen loss and follow-up percent diameter stenosis at different doses of oral valsartan six months after bare-metal stent implantation in type B2/C coronary lesions
Keywords: کاهش افت انعکاسی; Late lumen loss; Oral valsartan; Bare metal stent implantation; In-stent restenosis; Follow-up percent diameter stenosis
Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection
Keywords: کاهش افت انعکاسی; angiographic follow-up; coronary dissection; dissection healing; drug-coated balloon; DCB; drug-coated balloon(s); DES; drug-eluting stent(s); LLL; late lumen loss; MACE; major adverse cardiac event(s); MLD; minimal lumen diameter; PCI; percutaneous coron